STAAR Surgical ROE 2010-2023 | STAA
Current and historical return on equity (ROE) values for STAAR Surgical (STAA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| STAAR Surgical ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-12-31 |
$0.02B |
$0.39B |
6.04% |
| 2023-09-30 |
$0.02B |
$0.38B |
5.97% |
| 2023-06-30 |
$0.03B |
$0.35B |
7.71% |
| 2023-03-31 |
$0.03B |
$0.34B |
10.20% |
| 2022-12-31 |
$0.04B |
$0.34B |
13.00% |
| 2022-09-30 |
$0.04B |
$0.32B |
14.21% |
| 2022-06-30 |
$0.04B |
$0.30B |
13.67% |
| 2022-03-31 |
$0.03B |
$0.28B |
12.95% |
| 2021-12-31 |
$0.03B |
$0.26B |
11.70% |
| 2021-09-30 |
$0.02B |
$0.25B |
10.28% |
| 2021-06-30 |
$0.02B |
$0.24B |
10.10% |
| 2021-03-31 |
$0.01B |
$0.21B |
5.70% |
| 2020-12-31 |
$0.01B |
$0.20B |
3.32% |
| 2020-09-30 |
$0.01B |
$0.19B |
5.25% |
| 2020-06-30 |
$0.01B |
$0.18B |
4.31% |
| 2020-03-31 |
$0.01B |
$0.17B |
7.77% |
| 2019-12-31 |
$0.01B |
$0.16B |
8.81% |
| 2019-09-30 |
$0.01B |
$0.15B |
5.69% |
| 2019-06-30 |
$0.01B |
$0.14B |
5.17% |
| 2019-03-31 |
$0.01B |
$0.14B |
4.45% |
| 2018-12-31 |
$0.01B |
$0.13B |
5.59% |
| 2018-09-30 |
$0.00B |
$0.13B |
5.95% |
| 2018-06-30 |
$0.00B |
$0.05B |
8.84% |
| 2018-03-31 |
$0.00B |
$0.05B |
2.38% |
| 2017-12-31 |
$-0.00B |
$0.04B |
-5.03% |
| 2017-09-30 |
$-0.00B |
$0.04B |
-5.19% |
| 2017-06-30 |
$-0.01B |
$0.04B |
-13.25% |
| 2017-03-31 |
$-0.01B |
$0.04B |
-15.89% |
| 2016-12-31 |
$-0.01B |
$0.04B |
-31.58% |
| 2016-09-30 |
$-0.01B |
$0.04B |
-33.99% |
| 2016-06-30 |
$-0.01B |
$0.04B |
-33.55% |
| 2016-03-31 |
$-0.01B |
$0.04B |
-33.12% |
| 2015-12-31 |
$-0.01B |
$0.04B |
-18.06% |
| 2015-09-30 |
$-0.01B |
$0.04B |
-23.53% |
| 2015-06-30 |
$-0.01B |
$0.04B |
-25.97% |
| 2015-03-31 |
$-0.01B |
$0.04B |
-25.64% |
| 2014-12-31 |
$-0.01B |
$0.04B |
-22.36% |
| 2014-09-30 |
$-0.01B |
$0.04B |
-17.18% |
| 2014-06-30 |
$-0.00B |
$0.04B |
-7.50% |
| 2014-03-31 |
$-0.00B |
$0.04B |
-2.61% |
| 2013-12-31 |
$0.00B |
$0.04B |
0.00% |
| 2013-09-30 |
$0.00B |
$0.04B |
0.00% |
| 2013-06-30 |
$-0.00B |
$0.04B |
-3.01% |
| 2013-03-31 |
$-0.00B |
$0.03B |
-3.10% |
| 2012-12-31 |
$-0.00B |
$0.03B |
-3.15% |
| 2012-09-30 |
$0.00B |
$0.03B |
0.00% |
| 2012-06-30 |
$0.00B |
$0.03B |
0.00% |
| 2012-03-31 |
$0.00B |
$0.03B |
3.51% |
| 2011-12-31 |
$0.00B |
$0.03B |
3.77% |
| 2011-09-30 |
$0.00B |
$0.03B |
0.00% |
| 2011-06-30 |
$-0.00B |
$0.03B |
-4.30% |
| 2011-03-31 |
$-0.00B |
$0.02B |
-17.98% |
| 2010-12-31 |
$0.00B |
$0.02B |
0.00% |
| 2010-09-30 |
$0.00B |
$0.02B |
0.00% |
| 2010-06-30 |
$-0.00B |
$0.02B |
-4.55% |
| 2010-03-31 |
$0.00B |
$0.02B |
0.00% |
| 2009-12-31 |
$-0.01B |
$0.02B |
-30.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.307B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
